Biogen Inc. (FRA:IDP)
Germany
· Delayed Price · Currency is EUR 111.80
-0.95 (-0.84%)
Last updated: Jul 4, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Multiple Sclerosis | 4.35B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Multiple Sclerosis Growth | -8.36% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 2.46B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 7.73% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rare Disease | 1.99B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rare Disease Growth | 19.28% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Biosimilars | 793.10M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Biosimilars Growth | 0.32% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Alzheimer's Disease | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Product | 82.50M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Product Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 2.46B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 7.73% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Other | 2.46B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 4.88% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States | 3.24B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States Growth | 1.85% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
International | 3.98B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
International Growth | -0.65% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 2.46B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 4.88% |
Log In |
Log In |
Log In |
Log In | Upgrade
|